{"database": "lobbying", "table": "lobbying_activities", "rows": [[1628350, "ca0a5771-3f49-4f65-8c58-382d3005909f", "Q4", "HEARTLAND SOLUTIONS GROUP, INC.", 312133, "ZEBRA TECHNOLOGIES CORPORATION", 2014, "fourth_quarter", "PHA", "Any and all issues related to labeling of generic drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 9000, null, 0, 0, "2015-01-18T19:12:28.557000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1628350"], "units": {}, "query_ms": 18.848515930585563, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}